00:00You've partnered with a Swiss biotech company, Timeline.
00:03There's so much in this sort of realm of anti-aging and longevity.
00:09What sort of benefit, what edge do you have by teaming up with this Swiss biotech company?
00:15Hi, Dani. Very pleased to be with you to talk about this breakthrough partnership with Timeline.
00:22So this is for us, this is a step in our commitment to longevity science.
00:27It really reflects our open innovation strategy.
00:30You know, we think that today innovation is collective.
00:33So we are backed by our 4,000 scientists from the R&I of L'Oreal.
00:38But we are also actively building an avant-garde ecosystem by partnering with the most advanced scientific pioneers.
00:45And yes, this is our biggest scientific leap since Genefix Serum in 2009.
00:52Longevity is a societal revolution.
00:56Women want to live better, not just longer.
00:58And this is a massive opportunity for Lancôme to lead this new territory of growth.
01:03So it's a multi-year growth opportunity for us.
01:07So when I think longevity, I think about, you know, disease prevention, again, extending lives and making them more livable.
01:15Vanya, what is the line between that and just like anti-aging?
01:19Something that's been marketed towards women throughout the history of time and is often, you know, over-touted its benefits.
01:27Well, what is the line?
01:28Because I see you're specifically marketing this as longevity, not anti-aging.
01:33This is longevity.
01:35And longevity is not a trend.
01:38It's a real scientific reality.
01:40And obviously, we are entering the field of beauty.
01:44Beauty has a role to play in longevity because it's the first thing that you're saying.
01:48If the science works, then you can see it on your skin.
01:51So the way we approach it at Lancôme is that for us, longevity is this proactive, science-led, data-driven
01:57approach that acts at the root of the aging mechanism.
02:00So the way we've developed this new initiative is three ways.
02:06First, we have the asset.
02:07You always talk about asset in Bloomberg.
02:10Our asset is mitopure.
02:12This is the molecule that is within the longevity supplements by timeline.
02:17It's 15 years of research, 30 plus patent.
02:20It's over 50 million in R&D.
02:23And this is a – you can think of mitopure as a kind of, let's say, a cellular reboot.
02:29It helps the cells clean up, recharge, so that you can – your skin can behave, look years younger.
02:36But, Vanya, if I can just jump in, why is that longevity and not anti-aging?
02:41Longevity because it's acting at the root cause of aging, which means that it is able either to anticipate, to
02:47intercept, or to reverse your skin biological age.
02:50So this is the only age you can reverse.
02:53You know, your clinical age is the one you have, is the number of candles that you have on your
02:56birthday cake.
02:57But their skin biological age is the one that you can reverse.
03:00So actually, you can have a much younger biological age than your clinical age.
03:05How – where can you price this at?
03:08I know there's some concerns about the consumer, your parent company, some of the results, as I mentioned, weighed down
03:14by lack of travel, especially in areas like China.
03:16So are people willing to pay up top dollar for this type of product?
03:23You know, for us, what – the data that we have is that luxury is evolving, but it remains incredibly
03:29resilient when it's driven by high-value innovation, by performance.
03:33We see a clear shift from discretionary spending to investment spending in health and skin.
03:41So the luxury consumer wants efficacy that they can actually measure.
03:45So we are providing them a high-value skin care to manage their skin visible biological age, which is exactly
03:52what the premium consumer is looking for right now.
03:54At what point does prestige skin care, though, Vanya, hit a ceiling?
04:00I would say that for this range, we are proposing a price that is the most accessible of our absolute
04:07premium range.
04:08So this is, for us, a sweet spot that is able to provide to the consumer a proprietary formula, a
04:15delivery system, a key innovative ingredient in the most sensorial luxury skin care formulas.
04:21What about Lancome as a whole, Vanya?
04:24Are you still seeing appetite?
04:26How does the consumer look to you at this moment?
04:29I think that Lancome has always been this power of progress, and I think that investing in longevity science is
04:37the right move for us, and we are doing it in a very bold way.
04:42I think that you've seen that we've already made some partnership by the past.
04:46We've launched last year longevity PDRN molecules that is already showing that we can act at the biological level of
04:55the skin.
04:55We have also partnered with Timeline, with Nano and Tech, which is a Korean startup that allows us as well
05:03to have this fantastic new diagnosis.
05:06It's called Cell Bioprint.
05:09I don't know if you're familiar with it, but it's a kind of a lab on a chip.
05:12It's using microfluidics to really measure the proteins of the skin, and this is the way we can really measure
05:20now the skin biological age.
05:22So it's something that will really help us make the consumer understand what is the added value of our innovation.
05:29Vanya, I mean, just on that, South Korea feels like it's become this hub for skin tourism, if everyone going
05:35there, getting the latest injectable, the polynucleotide, what have you.
05:39Why does it feel like this is a region that's just so far ahead and so advanced, especially if you
05:44compare it, not in Europe, but especially America?
05:48You know, as I said, innovation today is collective.
05:52It's coming from everywhere.
05:53The U.S. is moving very fast.
05:56The longevity trend has really boomed in the U.S.
05:59We have all this medical community that is ramping up on the science.
06:04Asia is also very active.
06:06I would say that, yes, Korea, but not only.
06:08So we are getting all the collective passion and energy from all those zones to be able to provide the
06:18best innovation program that we can on the brand.
Comments